Consumer goods company Jatcorp (ASX:JAT) signed a sales incentive agreement with H&S International (HK) to boost sales of its Moroka lactoferrin brand in China, according to a Wednesday filing with the Australian bourse.
The company agreed to issue up to four million shares to H&S, subject to product purchase milestones of at least AU$8 million in the fiscal year and an accumulated AU$25 million across the current fiscal year and fiscal year 2026, the filing said.
The agreement is for an initial period from Jul. 1, 2024, to Jun. 30, 2026, with an option for extension based on mutual agreement, according to the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.